Ixazomib

Unravelling drug resistance and sensitization 2:15
Unravelling drug resistance and sensitization
Michel Delforge • 10 Mar 2021
Horizon scan: multiple myeloma treatment landscape 3:20
Horizon scan: multiple myeloma treatment landscape
Claudio Cerchione • 3 Mar 2021
Maintenance therapy in young patients with myeloma 4:55
Maintenance therapy in young patients with myeloma
Graham Jackson • 5 Mar 2021
Trial design for myeloma patients based on aging rather than age 2:36
Trial design for myeloma patients based on aging rather than age
Gordon Cook • 2 Mar 2021
Ide-cel CAR T-cell therapy for R/R myeloma in KarMMa-3 1:15
Ide-cel CAR T-cell therapy for R/R myeloma in KarMMa-3
Sergio Giralt • 14 Dec 2020
Real-world results of an in-class transition from VRd to IRd in myeloma 2:01
Real-world results of an in-class transition from VRd to IRd in myeloma
Joshua Richter • 4 Dec 2020
Dara plus IRd treatment for newly-diagnosed myeloma 4:22
Dara plus IRd treatment for newly-diagnosed myeloma
Morie Gertz • 2 Dec 2020
Ixazomib plus chemotherapy for AML & ALL 2:08
Ixazomib plus chemotherapy for AML & ALL
Amir Fathi • 24 Oct 2020
Ixazomib-based therapy for R/R myeloma in the real-world setting 5:45
Ixazomib-based therapy for R/R myeloma in the real-world setting
Heinz Ludwig • 26 Nov 2020
Prognostic importance of MRD: results of TOURMALINE-MM4 trial for NDMM 3:03
Prognostic importance of MRD: results of TOURMALINE-MM4 trial for NDMM
Bruno Paiva • 27 Nov 2020
DARIA: daratumumab with ixazomib and dexamethasone for R/R myeloma 2:38
DARIA: daratumumab with ixazomib and dexamethasone for R/R myeloma
Evangelos Terpos • 20 Nov 2020
Management of AL amyloidosis: what’s new? 4:48
Management of AL amyloidosis: what’s new?
Giampaolo Merlini • 5 Oct 2020
New developments in maintenance therapy for multiple myeloma 5:11
New developments in maintenance therapy for multiple myeloma
Graham Jackson • 2 Oct 2020
Outcomes of IRd in R/R multiple myeloma in routine clinical practice 4:26
Outcomes of IRd in R/R multiple myeloma in routine clinical practice
Xavier Leleu • 30 Sep 2020
TOURMALINE-AL1: ixazomib and dexamethasone for AL amyloidosis 1:57
TOURMALINE-AL1: ixazomib and dexamethasone for AL amyloidosis
Giampaolo Merlini • 24 Sep 2020
Daratumumab in the management of AL amyloidosis 5:07
Daratumumab in the management of AL amyloidosis
Morie Gertz • 23 Sep 2020
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals